Brett Drummond (Co-founder, MStranslate) is joined by Dr Travis Stiles (CEO, Novoron Bioscience) and Dr Joanna Cobbin (Team Member, MStranslate) to reflect on some of the key research outcomes presented throughout the second day of MS Milan 2023, the 9th Joint ECTRIMS-ACTRIMS Meeting and the world's largest multiple sclerosis (MS) research conference. Their discussion covers topics such as the gut microbiome, biomarkers, potential future therapeutic targets, environmental, genetic and epigenetic risk factors, AHSCT and Epstein-Barr virus (EBV), and more!
Learn more about MS Milan 2023 by visiting the event website at the following link - [ Ссылка ]
As referenced in the video, Brett is also host of The ECTRIMS Podcast, the event's official podcast. To listen to his in-depth Day 2 interview with Clare Walton, Head of Research at MS Society UK, click this link - [ Ссылка ]
Learn more about MStranslate and follow us on our other platforms via the links below:
Website: [ Ссылка ]
Facebook: [ Ссылка ]
Twitter: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Learn more about Dr Travis Stiles and the work of Novoron Bioscience by visiting their website - [ Ссылка ]
Music credit:
Music from #Uppbeat (free for Creators!):
[ Ссылка ]
License code: AFLNZVJKICSBWXMD
MS Milan 2023: Research Insights from Day Two
Теги
MS Milan 2023ECTRIMS 2023ECTRIMSmultiple sclerosisMSmultiple sclerosis researchmultiple sclerosis gut microbiomemultiple sclerosis risk factorsmultiple sclerosis treatmentsmultiple sclerosis cladribinemultiple sclerosis environmental riskmultiple sclerosis genetic riskmultiple sclerosis AHSCTmultiple sclerosis stem cell therapymultiple sclerosis epstein-barr virusmultiple sclerosis EBVMS Society UKBrett DrummondTravis StilesMStranslate